Trials / Completed
CompletedNCT01907204
Evaluation of Inhaled Treatment in Sinusitis
Evaluation of Inhaled Corticosteroid Treatment in Sinusitis
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether inhaled corticosteroid (specially nebulized) could be a good alternative to oral corticosteroid and whether they are effective in the treatment of sinusitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | methylprednisolone | Oral 32mg/8d-16mg/4d-8mg/4d |
| DRUG | Budesonide | Budesonide by metered dose inhaler |
| DRUG | Budesonide | Budesonide by nebulization |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2013-08-01
- Completion
- 2014-01-01
- First posted
- 2013-07-24
- Last updated
- 2014-01-27
Source: ClinicalTrials.gov record NCT01907204. Inclusion in this directory is not an endorsement.